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Introduction
During development, Schwann cells proliferate, migrate, sort, and ensheath individual axons, all of which contributes to the proper formation of myelin. Throughout these events, Schwann cells are in constant contact with axons, suggesting that glial-neuronal communication is essential for regulating these processes ( Bunge, 1993 ) . One such factor involved in Schwann cell proliferation and migration is neuregulin-1 (NRG1), which is expressed primarily by neurons and signals through the cognate ErbB family of receptors expressed by Schwann cells ( Bunge, 1993 ; Mahanthappa et al., 1996 ; Garratt et al., 2000 ; Citri et al., 2003 ) . Additionally, growing evidence clearly illustrates that NRG1 type III, a membrane-bound form, plays a critical role in the ensheathment and myelination of axons ( Nave and Salzer, 2006 ) . Although all of these processes are clearly distinct, they all require rapid and dynamic morphological changes in the Schwann cell, initiated by the activation of the ErbB2 and ErbB3 heterodimer of the receptor tyrosine kinase family ( Garratt et al., 2000 ; Citri et al., 2003 ) . How can the same ligand and receptor complex, namely NRG1 via ErbB2/3, regulate multiple cellular processes that are thought to be distinct and highly controlled in a temporal and spatial manner? How is specifi city conferred to generate the proper number of Schwann cells to appropriately match the number of axons and then to determine which axons should be myelinated?
It is well established that the ability of cells to respond to extracellular signals to change cell morphology is controlled in part by the Rho family of small GTPases, including Rac1, Cdc42, and RhoA ( Schmidt and Hall, 2002 ) . In fact, recent studies identify Rac1 as the downstream effector molecule responsible for process extension and lamellipodia formation in Schwann cells, allowing for proper radial sorting and myelination ( Benninger et al., 2007 ; Nodari et al., 2007 ) . The Rho GTPases are active when bound to GTP and are inactive when bound to GDP. Guanine nucleotide exchange factors (GEFs) catalyze the replacement of GDP with free cytoplasmic GTP to generate active GTPases, whereas GTPaseactivating proteins (GAPs) accelerate the intrinsic GTPase activity to inactivate the GTPases. Therefore, the rate-limiting step and the specifi city in the activation of the distinct GTPases lie in the expression and activation of both the GEFs and GAPs.
T he cellular events that precede myelination in the peripheral nervous system require rapid and dynamic morphological changes in the Schwann cell. These events are thought to be mainly controlled by axonal signals. But how signals on the axons are coordinately organized and transduced to promote proliferation, migration, radial sorting, and myelination is unknown. We describe that the axonal signal neuregulin-1 (NRG1) controls Schwann cell migration via activation of the atypical Dock180-related guanine nucleotide exchange factor (GEF) Dock7 and subsequent activation of the Rho guanine triphosphatases (GTPases) Rac1 and Cdc42 and the downstream c-Jun N-terminal kinase. We show that the NRG1 receptor ErbB2 directly binds and activates Dock7 by phosphorylating Tyr-1118. Dock7 knockdown, or expression of Dock7 harboring the Tyr-1118 -to -Phe mutation in Schwann cells, attenuates the effects of NRG1. Thus, Dock7 functions as an intracellular substrate for ErbB2 to promote Schwann cell migration. This provides an unanticipated mechanism through which liganddependent tyrosine phosphorylation can trigger the activation of Rho GTPase-GEFs of the Dock180 family.
ErbB2 directly activates the exchange factor Dock7 to promote Schwann cell migration cifi cally inhibits migration induced by NRG1 but not by NT3 or insulin-like growth factor (IGF)-I, which stimulates Schwann cell migration ( Cheng et al., 2000 Yamauchi et al., 2004 . These results again suggest that the DRG conditioned medium contains NRG1-like activity, which can enhance Schwann cell migration. We further investigated the effect of the NRG1-like activity on migration of reaggregated Schwann cells on live DRG axons to mimic physiological conditions. The Schwann cell reaggregates initially spread out slowly and then begin to migrate out of the reaggregates along axons. Addition of ErbB3-Fc to the culture medium of the DRG neurons inhibits Schwann cell migration from the reaggregates ( Fig. 1, H and I ). This observation is consistent with the results from our Boyden chamber assay and, in fact, ErbB3-Fc has a greater initial inhibitory effect on migration from the reaggregates. It is important to note that after a longer time course the effects on migration distances in the presence or absence of ErbB3-Fc were diminished. Thus, it is likely that the effect of ErbB3-Fc delays migration rather than completely inhibiting it.
We examined whether migration of Schwann cells requires the tyrosine kinase activity of ErbB2. Pretreatment with AG825, an inhibitor of the ErbB2 tyrosine kinase ( Tsai et al., 1996 ) , reduced NRG1-induced migration by ‫ف‬ 80% ( Fig. 1 , J and K ). In addition, we transfected siRNA oligonucleotides for both ErbB2 and 3 in Schwann cells. Expression of ErbB2 and 3 was specifi cally down-regulated after transfection with the siRNA, whereas expression of control proteins was unaffected, as revealed by immunoblotting ( Fig. 1 M ) . Knockdown of ErbB2 or ErbB3 attenuated migration induced by NRG1. Collectively, the ErbB2 and 3 heterodimer responds to NRG1, and the tyrosine kinase activity of ErbB2 is important for Schwann cell migration.
Next, we tested whether the Rho GTPases Rac1 and Cdc42 are involved in the NRG1-induced migration of Schwann cells, as previously seen in NT3-induced migration ( Yamauchi et al., 2004 ) . Pretreatment of Clostridium difficile Toxin B, which glycosylates and blocks the functions of Rho GTPases such as RhoA, Rac1, and Cdc42 ( Just et al., 1995 ) , inhibited the NRG1 effect by ‫ف‬ 70% ( Fig. 2 A ) . In contrast, C3 exoenzyme, which ADP ribosylates RhoA and blocks its function ( Hirose et al., 1998 ) , did not have any obvious effect. Furthermore, we transfected a siRNA for Rac1 or Cdc42 into Schwann cells. Knockdown of Rac1 inhibited the NRG1-induced migration in Boyden chambers by ‫ف‬ 25% (Fig. S1 D, available at http://www .jcb.org/cgi/content/full/jcb.200709033/DC1) as well as migration from reaggregates on DRG axons (compare videos 1 -4 for cells transfected with control siRNA with videos 5 and 6 for cells transfected with Rac1 siRNA, available at http://www.jcb .org/cgi/content/full/jcb.200709033/DC1), which is consistent with recent studies ( Benninger et al., 2007 ; Nodari et al., 2007 ) . Transfection with nonoverlapping siRNA, Cdc42-1 or Cdc42-2, decreased the migration in Boyden chambers by ‫ف‬ 15 and 25%, respectively (Fig. S1 , E and F), as well as decreasing the migration from reaggregates on DRG axons (videos 7 and 8 for cells transfected with Cdc42-2 siRNA). However, because the effect after knockdown of Rac1 or Cdc42 is weaker than that of Toxin B, it is possible that Rac1 activity transduces an intracellular The GEFs are largely divided into two major categories ( Rossman et al., 2005 ) . The fi rst category is composed of ‫ف‬ 80 genes related to the protooncogene Dbl . These gene products share a catalytic Dbl homology (DH) domain, which was fi rst identifi ed over a decade ago ( Schmidt and Hall, 2002 ; Rossman et al., 2005 ) . The second category consists of at least 11 GEFs, which contain a catalytic domain that is structurally distinct from the DH domain. This catalytic domain is named the Dock homology region (DHR)-2 (also called Caenorhabditis elegans Ced-5 / mammalian Dock180 / Drosophila melanogaster Mbc-zizimin homology domain 2 or Docker; Rushton et al., 1995 ; Hasegawa et al., 1996 ; Wu and Horvitz, 1998 ; Brugnera et al., 2002 ; C ô t é and Vuori, 2002 ; Meller et al., 2002 ; Rossman et al., 2005 ) and, until recently, little was known about the mechanisms that regulate the activities of the Dock180 (also called Dock1)-related GEFs. In this paper, we report the role of the atypical Dock180-related GEF Dock7 and the subsequent GTPase signaling cascade in NRG1-induced migration of primary Schwann cells. Furthermore, we identify Dock7 as the functional intracellular substrate of ErbB2, suggesting the importance of Dock7 in early peripheral nervous system development.
Results

NRG1 activation of ErbB2 and 3 promotes Schwann cell migration through Rho GTPases Rac1 and Cdc42 and the downstream JNK
Using Boyden chambers, we previously demonstrated that dorsal root ganglion (DRG) neurons secrete various growth factors, including neurotrophin-3 (NT3) and brain-derived neurotrophic factor, to regulate Schwann cell migration ( Yamauchi et al., 2004 ) . We placed primary Schwann cells onto fi lters of Boyden chambers coated with axonal membranes from DRG neurons and allowed them to migrate into the lower compartment along a concentration gradient of the neuronal conditioned medium for 6 h. When we added the NRG1 scavenger ErbB3-Fc to the DRG conditioned medium, migration was signifi cantly diminished. Removal of the NRG1-like activity inhibited migration by ‫ف‬ 80% ( Fig. 1, A and B ) , implicating NRG1 as a positive regulator of Schwann cell migration. We next examined the effects of extracellular matrix proteins on Schwann cell migration induced by the conditioned medium. Filters in the Boyden chambers were coated with collagen (type I or IV), fi bronectin, or laminin ( Fig. 1, C and D ) . The conditioned medium stimulated migration on any of the extracellular matrices, although fibronectin and laminin enhanced Schwann cell migration in the absence of the conditioned medium. Therefore, it is possible that extracellular matrices act cooperatively with soluble factors to control migration. In contrast, the collagen-coated fi lters were similar to the fi lters coated with DRG axonal membranes. Because collagen modestly stimulates migration as compared with fi bronectin and laminin, collagen (type I)-coated fi lters were used in the subsequent experiments. Next, we explored whether ErbB3-Fc is specifi c for the NRG1-like activity in the conditioned medium. As shown in Fig. 1 (E -G) , ErbB3-Fc spe- The migration of primary Schwann cells was measured by using Boyden chambers. Filters were coated with DRG axonal membranes. After incubation for 6 h with normal or conditioned medium from DRG neurons containing 5 μ g/ml of control IgG or ErbB3-Fc, Schwann cells were stained with Giemsa solution and the number of migrating cells was counted (16 independent fi elds). Bar, 50 μ m. (C and D) Filters in Boyden chambers were coated with DRG axonal membranes, collagen (type I or IV), fi bronectin, or laminin. Schwann cell migration was measured in the presence of normal medium or conditioned medium (eight independant fi elds). (E -G) In the presence of control IgG or ErbB3-Fc, Schwann cells were incubated with or without 20 ng/ml of NRG1, NT3, or IGF-I in Boyden chambers (eight independent fi elds). Filters were coated with collagen (type I). (H and I) Schwann cell reaggregates were placed onto DRG neurons and control IgG or ErbB3-Fc was added. After 6 h, DRG axons were stained with an antineurofi lament antibody (red), and Schwann cells were stained with an anti-S100 ␤ antibody (green). The distance of migration was measured ( n = 16). Bar, 100 μ m. (J and K) Schwann cells were pretreated in the presence or absence of 10 μ M AG825 and then incubated with or without 20 ng/ml NRG1 in Boyden chambers. The number of migrating cells was counted (16 independent fi elds). Bar, 50 μ m. (L and M) Schwann cells were transfected with control, ErbB2, or ErbB3 siRNA and incubated with or without NRG1 in Boyden chambers (16 independent fi elds). To confi rm the effects of siRNAs, the lysates of transfected cells were immunoblotted with an anti-ErbB2, ErbB3, or actin antibody. Error bars show ± SD. Data were evaluated by using one-way ANOVA (*, P < 0.01; ***, P < 0.02).
2004 ) on NRG1-induced migration. SP600125 and JNK inhibitor I inhibited the NRG1 effect by ‫ف‬ 80 and 70%, respectively ( Fig. 3 A ) . We next immunoblotted with an antiphosphorylated JNK antibody that recognizes the phosphorylated or active state of JNK. JNK phosphorylation was detected in a time-dependent manner, and the level of phosphorylation reached maximum at 120 min and gradually decreased afterward ( Fig. 3, B -E ). In addition, C. diffi cile Toxin B inhibited the JNK phosphorylation by ‫ف‬ 70% ( Fig. 3 F ) , indicating that JNK is one of the transducers acting downstream of Rac1 and Cdc42 in Schwann cell migration.
The atypical GEF Dock7 mediates NRG1-induced Schwann cell migration
To identify the specifi c GEFs involved in the NRG1 regulation of Rac1 and Cdc42, we designed siRNA against Tiam1 and Dbs, major GEFs of the Dbl family for Rac1 and Cdc42, respectively, in Schwann cells ( Yamauchi et al., 2005a , b ) . Neither Tiam1 nor Dbs knockdown had any effect on the NRG1-induced migration of Schwann cells (Fig. S1, A and B) . Therefore, we examined the involvement of Dock7, a Dock180-related GEF signal from NRG1 together with Cdc42 and that Rac1 and Cdc42 may share a common downstream signaling pathway. To examine whether NRG1 directly activates Cdc42 and Rac1, we performed affi nity precipitation using the Rac1-GTP and Cdc42-GTP binding domain of Pak1. The activities of Rac1 and Cdc42 reached maximum levels at 60 -120 min after stimulation with NRG1 and remained activated for at least 360 min ( Fig. 2, B -I ) . Therefore, NRG1 activation of ErbB2 and 3 can stimulate the increase of Rac1-GTP and Cdc42-GTP to enhance Schwann cell migration.
We previously reported that JNK acts downstream of Rac1 and Cdc42 in NT3-induced migration of Schwann cells ( Yamauchi et al., 2005a , b ) . In addition, the JNK cascade is the direct target of Rho GTPases in many other types of cells ( Schmidt and Hall, 2002 ) . Therefore, we investigated the effect of structurally unrelated JNK inhibitors SP600125 and JNK inhibitor I ( Heo et al., Figure 2 . NRG1-induced migration of Schwann cells is dependent on the activation of the Rho GTPases Rac1 and Cdc42. (A) Schwann cells were pretreated with or without 2 ng/ml C. diffi cile Toxin B or 2 μ g/ml C3 exoenzyme, and migration was assayed in Boyden chambers (12 independent fi elds). (B and C) After the addition of NRG1 for 0 -120 min, endogenous Rac1-GTP in the lysates of Schwann cells was affi nity precipitated with GST-Pak1-CRIB and immunoblotted with an anti-Rac1 antibody. The levels of Rac1-GTP were normalized to the amount of total Rac1 ( n = 3). (D and E) The Rac1 activities were measured at 0 -360 min ( n = 5). (F -I) Endogenous Cdc42-GTP in the cell lysates was affi nity precipitated with GST-Pak1-CRIB. The Cdc42-GTP levels were normalized to the amount of total Cdc42 ( n = 3). Error bars show ± SD. Data were evaluated by using one-way ANOVA (*, P < 0.01). (B and C) Schwann cells were stimulated with NRG1 for 0 -120 min. The cell lysates were immunoblotted with an anti-(pThr 183 /pTyr 185 ) JNK antibody that recognizes active JNK. The cell lysates were also immunoblotted with an anti-JNK antibody. The levels of phosphorylated forms were normalized to the amount of total JNK ( n = 3). (D and E) JNK phosphorylation was measured at 0 -360 min ( n = 3). (F) Cells were pretreated with or without 2 ng/ml C. diffi cile Toxin B. After incubation with NRG1 for 120 min, JNK phosphorylation was assayed ( n = 5). Error bars show ± SD. Data were evaluated by using one-way ANOVA (*, P < 0.01). and 3 heterodimer and apparently possesses various tyrosine phosphorylation sites. The recombinant intracellular kinase domain of ErbB2 (HTScan ErbB2 kinase) phosphorylated the purifi ed wild-type Dock7 protein (Fig. S3 B) and coprecipitated with Dock7 in vitro ( Fig. 6 A ) . To investigate the potential sites on Dock7 that could be tyrosine phosphorylated by ErbB2, we transfected a plasmid encoding the N-terminal region containing DHR-1 (aa 1 -691), middle region 1 (aa 692 -1110), middle region 2 (aa 1111 -1431), or DHR-2 (aa 1432 -1992) into 293T cells ( Fig. 6 B ) . Because the amino acid sequence positioned between DHR-1 and -2 is quite extensive, it was divided into two regions. The ErbB2 kinase coprecipitated with both middle regions expressed abundantly in Schwann cells (Fig. S1 C) . Transfection of nonoverlapping siRNA, Dock7-1 or Dock7-2, into Schwann cells knocked down the expression of endogenous Dock7, as revealed by immunoblotting with an anti-Dock7 antibody (Fig. S2 , A -C). Dock7-1 or -2 siRNA inhibited the NRG1-induced migration in Boyden chambers by ‫ف‬ 70 and 50%, respectively ( Fig. 4, A and B ) , as well as inhibiting migration from reaggregates on DRG axons (videos 9 and 10 for cells transfected with Dock7-1 siRNA, available at http://www.jcb.org/cgi/content/ full/jcb.200709033/DC1). Similarly, knockdown of Dock7 by Dock7-1 siRNA reduced the NRG1 activation of Rac1 by ‫ف‬ 80%, Cdc42 by 80%, and JNK phosphorylation by 60% ( Fig. 4 , C -E ). Despite the potential involvement of other GEFs in these signaling pathways, our results hint at the possible role for Dock7 in Schwann cell migration and provide the rationale and impetus for the subsequent experiments.
ErbB2 directly binds and activates Dock7
by phosphorylating Tyr-1118 to regulate
Schwann cell migration
Because the DHR-2 domain of the Dock180-related GEFs shows catalytic activity ( Brugnera et al., 2002 ; C ô t é and Vuori, 2002 ; Meller et al., 2002 ) , we tested whether Rho GTPases could be activated by the DHR-2 domain of Dock7. The purifi ed DHR-2 domain ( Fig. S3 A, available at http://www.jcb.org/cgi/content/ full/jcb.200709033/DC1) promoted the exchange, binding, and release of the guanine nucleotide for Rac1 and Cdc42 in a timedependent manner ( Fig. 5, A , B, D, and E ), whereas no effect was observed for RhoA ( Fig. 5, C and F ) . Catalytically active GEFs preferentially interact with guanine nucleotide -free forms of the small GTPases ( Arthur et al., 2002 ; Schmidt and Hall, 2002 ; Rossman et al., 2005 ) . A Gly-to-Ala mutation in the P loop of the small GTPases decreases their guanine nucleotide binding activities ( Arthur et al., 2002 ) . We performed an affi nity precipitation of the DHR-2 domain of Dock7 with guanine nucleotidefree Rac1G15A, Cdc42G15A, or RhoAG17A as well as wild-type Rac1, Cdc42, or RhoA. DHR-2 specifi cally coprecipitated with Rac1G15A ( Fig. 5 G ) and Cdc42G15A ( Fig. 5 I ) but not with RhoAG17A ( Fig. 5 K ) , which is consistent with the results from the guanine nucleotide exchange assays. In contrast, the DH and pleckstrin homology (PH) domains of Dbs affi nity preci pitated with Rac1G15A ( Fig. 5 H ) or Cdc42G15A ( Fig. 5 J ) as well as with RhoAG17A ( Fig. 5 L ) . Similarly, the affinity precipitation with wild-type Rac1 or Cdc42 also showed binding to DHR-2 but was slightly weaker than the precipitation with each GTPase harboring the Gly-to-Ala mutation. To investigate whether NRG1 activation of the ErbB2 and 3 heterodimer stimulates the GEF activity of Dock7, we cotransfected the plasmids encoding wild-type Dock7, ErbB2, and ErbB3 into 293T cells and measured the exchange of the guanine nucleotide from immunoprecipitated Dock7 for Rac1 and Cdc42. The activity of wild-type Dock7 was signifi cantly increased after stimulation with NRG1 ( Fig. 5, M and O ) . Similarly, NRG1 promoted the affi nity-precipitation of Dock7 with Rac1G15A or Cdc42G15A ( Fig. 5, N and P ) .
We asked if ErbB2 could directly phosphorylate Dock7 because Dock7 is stimulated after the activation of the ErbB2 To confi rm the effects of siRNA, the lysates of transfected cells were immunoblotted with an anti-Dock7, Rac1, Cdc42, or actin antibody. (C and D) Schwann cells were transfected with control or Dock7-1 siRNA and stimulated with NRG1 for 60 min. The activities of Rac1 and Cdc42 were assayed by affi nity precipitation with GST-Pak1-CRIB ( n = 3). (E) Cells were transfected with control or Dock7-1 siRNA and JNK phosphorylation was measured ( n = 3). Error bars show ± SD. Data were evaluated by using one-way ANOVA (*, P < 0.01).
Y1375F, and Y1429F mutants of the full-length Dock7 and analyzed the phosphorylation by the ErbB2 kinase. In Fig. 6 F , the Y1118F mutation greatly reduced the phosphorylation of Dock7 by the ErbB2 kinase, whereas the Y1138F, Y1225F, Y1233F, Y1375F, and Y1429F mutations did not possess inhibitory effects on phosphorylation. Similarly, the purifi ed Y1118F Dock7 (Fig. S3 C) reduced phosphorylation by the ErbB2 kinase ( Fig. 6 G ) . Amino acid sequences surrounding Tyr-1118 in Dock7 are uniquely conserved among mammalian Dock7 proteins but not in the Dock180-related GEFs homologous to Dock7 and those from other species ( Fig. 6 H ) .
To clarify whether ErbB2 directly activates Dock7 and whether Tyr-1118 is critical for ErbB2-dependent GEF activity, we incubated the purifi ed wild-type or Y1118F Dock7 with the ErbB2 kinase and performed guanine nucleotide release assays in vitro. ErbB2 stimulated guanine nucleotide release and phosphorylated the middle region 2 ( Fig. 6 C ) . These results are also supported by fi ndings that the middle region 2, acting as a specifi c substrate for ErbB2, has a dominant-negative effect on NRG1-induced migration (Fig. S4 , A -D, available at http://www.jcb.org/cgi/content/full/jcb.200709033/DC1) and activation of Rac1 (Fig. S4 , E, F, and I) and Cdc42 (Fig. S4 , G, H, and J). Because the middle region 2 of Dock7 contains six tyrosine residues that may be phosphorylated by ErbB2 ( Fig. 6 D ) , we made a series of constructs harboring Tyr-to-Phe mutations in the middle region 2. The ErbB2 kinase had the ability to phosphorylate the Y1138F, Y1225F, Y1233F, Y1375F, and Y1429F mutants but could not effectively phosphorylate the Y1118F mutant ( Fig. 6 E ) . The Y1138F mutation of the middle region 2 modestly inhibited phosphorylation by the ErbB2 kinase. Thus, to ascertain whether Tyr-1118 is the major phosphorylation site of Dock7, we made the Y1118F, Y1138F, Y1225F, Y1233F, of Dock7 for Rac1 and Cdc42, whereas the Y1118F mutation in Dock7 abolished the release ( Fig. 6, I and J ). These results provide evidence that ErbB2 directly binds to Dock7 and phosphorylates the Tyr-1118 position to activate Rac1 and Cdc42 in vitro.
To explore whether ErbB2 phosphorylates endogenous Dock7 in Schwann cells, we made an antibody specifi c to phosphorylated Tyr-1118 of Dock7 (Fig. S2, D and E) . Stimulation with NRG1 dramatically enhanced the phosphorylation of Tyr-1118, and this phosphorylation was reduced by AG825 or ErbB3-Fc ( Fig. 7 A ) . NT3 or IGF-1 did not enhance the phosphorylation of Dock7, indicating that the Tyr-1118 position is specifi c for NRG1. In addition, Dock7 was immunoprecipitated with ErbB2, and this interaction was enhanced by stimulation with NRG1 ( Fig. 7 B ) . Stimulation with NRG1 also increased the colocalization of Dock7 with ErbB2 ( Fig. 7 C , bottom) and phosphorylated Dock7 at Tyr-1118 with ErbB2 ( Fig. 7 C , middle) in cell bodies and in processes. In addition, after stimulation with NRG1, colocalization of phosphorylated Dock7 with phosphorylated ErbB2 was observed in punctate structures ( Fig. 7 C , top) . Furthermore, NRG1 induced an affi nity precipitation of Dock7 with Rac1G15A or Cdc42G15A ( Fig. 7, D and E ) . Thus, stimulation with NRG1 can promote the binding of Dock7 with ErbB2, phosphorylate Dock7 at the Tyr-1118 position, and regulate the Dock7 activity in Schwann cells.
Next, we investigated the role of the phosphorylation of Dock7 at the Tyr-1118 position in Schwann cell migration. We cotransfected a plasmid encoding Dock7-1 siRNA-resistant wild-type or Y1118F Dock7 together with a control or Dock7-1 siRNA into Schwann cells. Expression of siRNA-resistant wildtype Dock7 reversed the Dock7-1 siRNA-mediated inhibition of NRG1-induced migration in Boyden chambers, whereas Y1118F Dock7 failed to rescue Dock7-1 siRNA-mediated inhibition of migration ( Fig. 8, A and B ) . Because there is the possibility that the Y1118F mutation has an effect on the protein conformation of Dock7, we tested the effects of the other mutants, Y1138F, Y1225F, Y1233F, Y1375F, and Y1429F, on migration. The Y1138F, Y1225F, Y1233F, or Y1375F mutant rescued siRNA-mediated inhibition of migration at the same level as that of the wild type ( Fig. 8, D and E ) , indicating that the Y1118F mutation mimics the nonphosphorylated form and that the phosphorylation at the Tyr-1118 position is required for migration. The Y1429F mutant could rescue siRNA-mediated inhibition of migration but did not completely. The reason may be that Tyr-1429 interacts functionally with the catalytic DHR-2 because it is adjacent to DHR-2. Alternatively, because the Tyr-1429 position is contained in the canonical phosphatidylinositol-3-kinase binding motif Tyr-X-X-Met ( Fig. 5 D ; Ponzetto et al., 1993 ) , the binding may partially affect Dock7 activation ( C ô t é et al., 2005 ). Expression of Dock7-1 siRNA-resistant constructs was not down-regulated by cotransfection with Dock7-1 siRNA, which specifi cally reduced expression of native siRNA-sensitive nucleotide sequence of Dock7 ( Fig. 8 C ) .
Consistent with the results in the previous paragraph, expression of Dock7-1 siRNA-resistant wild-type Dock7 reversed Dock7-1 siRNA-mediated inhibition of NRG1-induced migration from reaggregates on DRG axons ( Fig. 9, A and B ) . In contrast, expression of siRNA-resistant Y1118F Dock7 did not rescue siRNA-mediated inhibition of migration. These results indicate again that the phosphorylation of Dock7 at the Tyr-1118 position by ErbB2 plays a key role in promoting Schwann cell migration.
Discussion
Each stage in Schwann cell development involves characteristic morphological changes regulated by reciprocal and complex glial -neuronal interactions. Membrane-bound NRG1, expressed primarily on axons, represents an essential determinant in controlling myelination by Schwann cells ( Nave and Salzer, 2006 ) . In this paper, we demonstrate that NRG1 binding to the ErbB2 and 3 heterodimer promotes migration of premyelinating Schwann cells and that this effect is mediated by the direct activation of the Dock180-related GEF Dock7 and the subsequent Rho GTPase cascade. This conclusion is supported by the fi ndings that blocking the signaling molecules coupling the ErbB receptor to the Rho GTPase cascade results in the attenuation of migration. Importantly, we identify Dock7 as the functional intracellular substrate for the ErbB2 receptor. ErbB2 directly binds to Dock7 and promotes the GEF activities for Rho GTPases by phosphorylating Tyr-1118 in vitro. Stimulation with NRG1 in Schwann cells leads to the phosphorylation of Dock7 at Tyr-1118 and activation. Transfection of Dock7 harboring the Tyr-1118 -to -Phe mutation inhibits the NRG1-induced migration. These results demonstrate that NRG1 activation of the ErbB2 and ErbB3 heterodimer induces Schwann cell migration through an unexplored mechanism, namely that a receptormediated tyrosine phosphorylation event triggers the activation of Dock7. Dock7 has a GEF activity that is preferential for Cdc42 rather than Rac1; however, Schwann cell migration by NRG1 requires both Rac1 and Cdc42. Because Schwann cells modestly express Dock3, 4, and 5 of the Rac1-specifi c Dock180-related GEFs, they may cooperatively support the remaining NRG1-dependent Rac1 activity.
Possible alternative regulation of Dock7 in Schwann cell migration
It is clear that ErbB2 phosphorylates and activates Dock7 in vitro; however, the question of whether Dock7 can be activated by an alternative mechanism remains. Besides the catalytic DHR-2 domain, Dock180-related GEFs contain another conserved domain, termed DHR-1 (also called City-zizimin homology domain 1). The putative phospholipid-binding C2 domain is found in the DHR-1 domain of Dock180. Dock180 binds to phosphatidylinositol-3,4,5-triphosphate, the product of phosphatidylinositol-3-kinase ( C ô t é et al., 2005 ). Because ErbB2 can activate phosphatidylinositol-3-kinase ( Garratt et al., 2000 ; Citri et al., 2003 ) , it is possible that phosphatidylinositol-3,4,5-triphosphate modulates cellular functions of Dock7. Dock180 also has some protein -protein interactive domains. Dock180 interacts with the proline-rich region of engulfment and cell motility (ELMO) family proteins and the Src homology (SH) 3 domain of CrkII through the N-terminal SH3 domain and the C-terminal proline-rich sequence, respectively ( Hasegawa et al., 1996 ; Brugnera et al., 2002 ) .
GTP -ELMOs -CrkII -Dock180 complex induces morphological changes at the cell periphery. However, Dock7 does not interact with ELMO1 and CrkII (Fig. S5 , available at http://www.jcb .org/cgi/content/full/jcb.200709033/DC1) because it is unlikely that Dock7 contains either an SH3 domain or a proline-rich region. It will be of interest to examine the binding partners of Dock7
The ELMOs -CrkII -Dock180 complex is required for activating Rac1 along the periphery of a cell, leading to lamellipodial formation. The activation of Rac1 through Dock180 has an alternative mechanism when dealing with the Rho GTPase RhoG. Once activated, RhoG forms a ternary complex with ELMOs -CrkII -Dock180 ( Katoh and Negishi, 2003 ) . The RhoG- (A and B) pEGFP or pEGFP-siRNA -resistant wild-type Dock7 or Dock7Y1118F was cotransfected with control or Dock7-1 siRNA into Schwann cells. Cells were fi xed with PFA, blocked, and stained with an anti-neurofi lament antibody (red). The immuno fl uorescence images were merged. Bar, 100 μ m. Error bars show ± SD. Data were evaluated by using one-way ANOVA ( n = 16; *, P < 0.01; **, P < 0.015; ***, P < 0.02).
Cdc42 regulate actin polymerization by activating the Arp2/3 complex through their effectors, the Wiskott-Aldrich syndrome protein (WASP) and the WASP family verprolin homologous protein families ( Takenawa and Miki. 2001 ) . In addition, the Rac1 and Cdc42 effector Pak family controls actin fi lament dynamics by phosphorylating myosin light chain kinases or LIM domain kinases ( Zhao and Manser, 2005 ) . The JNK signal is a key downstream effector of the Dock7-activated Rho GTPases in Schwann cell migration, but it is conceivable that effector proteins such as WASP, WASP family verprolin homologous protein, and Pak families can also infl uence migration by altering the actin cytoskeleton. Further studies may explain how signals through Rho GTPases are coordinately transduced with JNK to induce cell migration.
JNK has been originally identifi ed as the kinase that phosphorylates the transcription factor c-Jun. Indeed, fi broblast migration likely requires c-Jun phosphorylation, but JNK has some key substrates that include cytoskeletal components ( Huang et al., 2004 ) . One particular JNK substrate candidate implicated in cell migration is the focal adhesion adaptor protein paxillin because JNK phosphorylates paxillin to regulate migration of bladder tumor epithelial NBT-II cells ( Huang et al., 2003 ) . Additionally, another candidate molecule may be the microtubule-associated proteins (MAPs). Mice defi cient in JNK1, as well as pharmacological inhibition of JNK activity, exhibit a progressive morphological alteration associated with defective neuronal migration ( Chang et al. 2003 ; Kawauchi et al., 2003 ) . Hypophosphorylation of MAP2 and MAP1B is also observed with an increase in microtubule stability, although it is unclear whether JNK regulates micro tubule dynamics by phosphorylating MAP2 and MAP1B. Because paxillin, MAP2, and MAP1B are widely expressed and control various cellular functions, they may act cooperatively as targets of JNK to assist migration of Schwann cells.
In the present study, we identify Dock7 as a downstream effector of ErbB2. This interaction mediates NRG1-induced migration of premyelinating Schwann cells. It is noteworthy to add that NRG1, acting through the ErbB2 and 3 heterodimer, enhances myelination by Schwann cells ( Bunge, 1993 ; Garratt et al., 2000 ; Citri et al., 2003 ) as well as migration. Because migration precedes myelination, certain mechanisms may be preserved in both processes. Myelination by Schwann cells is mediated by the polarity protein Par-3, whose complex generally involves the Rac1 and Cdc42 effector Par-6 ( Chan et al., 2006 ) . Recently, Watabe-Uchida et al. (2006) reported that Dock7 regulates the polarity formation of axons and dendrites through Rac1 in hippocampal neurons. It is possible that the Dock7-mediated Rho GTPase activation may lead to the formation of a polarity complex that will ultimately trigger myelination. The chemical compound NSC23766 is a fi rst generation Rac1-specifi c inhibitor identifi ed by a structure-based in silico screening ( Gao et al., 2004 ) . It fi ts into a small GTPase binding groove on the Rac1-specifi c GEFs Tiam1 and Trio of the Dbl family. The development of chemical inhibitors specifi c for Dock7 and the in vivo application of siRNA oligonucleotides will help to elucidate the role of Dock7 in the myelination process both in vitro and in vivo, as well as in various pathological states originating from aberrant regulation of the ErbB receptors ( Tsai et al., 1996 ; Citri et al., 2003 ) .
(Invitrogen) containing 10% FBS and 100 ng/ml NGF on collagen-coated dishes ( Yamauchi et al., 2004 ) . After 2 -3 wk, DRG neurons were cultured in DME-GlutaMax containing 10% FBS and 20 ng/ml NGF. 293T and Cos-7 cells (Human Science Research Resource Bank) were cultured in tissue culture dishes in DME containing 10% FBS, 50 U/ml penicillin, and 50 μ g/ml streptomycin, and Cos-7 cells were plated for experiments on collagen-coated dishes. Before the experiments, 293T and Cos-7 cells were cultured in DME containing 1% FBS and 1 mg/ml BSA for 24 h. Unless otherwise indicated, Schwann cells and Cos-7 cells were pretreated with or without 2 ng/ml C. diffi cile Toxin B for 24 h, 2 μ g/ml C3 exoenzyme for 24 h, 10 μ M AG825 for 45 min, 10 μ M SP600125 for 45 min, or 20 μ M JNK inhibitor I for 24 h before stimulation with 20 ng/ml NRG1 (R & D Systems), NT3 (PeproTech), or IGF-I (Invitrogen) for 0 -360 min. To confi rm cell viability under these experimental conditions, Schwann cells and Cos-7 cells were stained with 0.4% trypan blue. Trypan blue -incorporating cells were < 1% in each experiment.
Boyden chamber migration assay
Cell migration was routinely measured using a 24-well Boyden chamber, as previously described ( Yamauchi et al., 2004 ) . In brief, in the case of assaying the effect of ErbB3-Fc on DRG neurons ' conditioned medium, polyethylene terephthalate (8-μ m pore size) fi lters were coated with axonal membranes from DRG neurons ( Grimes et al., 1996 ) . In other experiments, fi lters were essentially coated with collagen (type I), except for the comparison of extracellular matrix proteins collagen (type IV), fi bronectin, and laminin. Cells (0.5 × 10 5 cells for Schwann cells or 5 × 10 5 cells for Cos-7 cells) in 500 μ l of normal medium per well were loaded into the upper chambers, which were inserted into the tissue culture wells in 750 μ l of conditioned medium containing 5 μ g/ml anti-NGF antibody in the presence of 5 μ g/ml of control IgG or ErbB3-Fc per well or in normal medium containing 50 ng/ml NRG1, NT3, or IGF-I per well. After incubation at 37 ° C for 6 h, the fi lters were stained with Giemsa solution or fi xed with PFA to detect cells expressing GFP. No difference in cell number was observed at 6 h in the presence or absence of NRG1, NT3, or IGF-1. The number of stained or GFP-fl uorescent migrating cells at the bottom surface of the fi lters was counted at four fi elds per fi lter in two to four independent experiments. In the presence of 5 μ g/ml of control IgG or ErbB3-Fc for 8 h, trypan blue -incorporating cells were < 0.5%.
Migration assay using reaggregated Schwann cells
To mimic physiological conditions, Schwann cell migration was also measured using DRG neurons and reaggregated Schwann cells essentially as described previously ( Yamauchi et al., 2004 ) . In brief, DRG neurons were plated onto the center of a collagen-coated dish and allowed to extend axons outwardly. Schwann cell reaggregates were formed by plating Schwann cells on Ultra Low Attachment dishes (Corning) for 4 h and on Petri dishes (Barloworld Scientifi c) for 20 h with gentle agitation every 3 -4 h. In the case of analyzing the effect of 5 μ g/ml ErbB3-Fc, 5 μ g/ml anti-NGF antibody was added into culture medium of DRG neurons. For the other experiments, the medium was changed into normal medium containing vehicle or 20 ng/ml NRG1. Individual Schwann cells were allowed to migrate out of the reaggregates along the axons. After incubation at 37 ° C for 6 h, cells were fi xed with PFA, blocked, and immunostained. The distance of migration was calculated by measuring the size of the reaggregates over time, subtracting the mean initial size of the reaggregates, and dividing the remaining distance in half. Experiments were performed by measuring eight reaggregates per dish in two independent experiments.
Fluorescence images
Cells on collagen-coated glass coverslips or fi lters of Boyden chamber and reaggregated Schwann cells were air-dried, fi xed with 4% PFA, blocked with Immuno-Block (Dainippon Sumitomo Pharma) in phosphate-buffered saline -0.1% Tween-20, incubated with primary antibodies, and treated with fl uorescence-labeled secondary antibodies. The coverslips and fi lters were mounted with Vectashield (Vector Laboratories) onto slides for observation by confocal and fl uorescence microscopy. The confocal images were collected with a microscope (IX81; Olympus) with a laser-scanning FV500 system (Olympus) and analyzed with FluoView software (Olympus). The primary antibodies used for confocal images were anti-Dock7, anti-(pTyr 1118 )Dock7, anti-ErbB2, and anti-(pTyr 1112 )ErB2. The fl uorescence images were captured with a microscope system (TE-300; Nikon) and analyzed with AxioVision software (Carl Zeiss, Inc.). The primary antibodies used for the fl uorescence images were anti-S100 ␤ to identify Schwann cells when GFP constructs were not transfected and anti-neurofi lament to identify DRG axons. The live imaging was performed using a microscope
Materials and methods
Antibodies and inhibitors
The following antibodies were purchased: anti-ErbB2, anti-ErbB3, anti-JNK1, anti-Tiam1, anti-Dbs, anti-HA, and anti-MBP (Santa Cruz Biotechnology, Inc.); anti-autophosphorylated (Tyr 1112 ) ErbB2 (Invitrogen); anti-phosphorylated active (pThr 183 /pTyr 185 ) JNK (Cell Signaling Technology); antiphosphorylated Tyr (pTyr) and anti-NGF (Millipore); anti-Rac1, anti-Cdc42, and anti-actin (BD Biosciences); anti-S100 ␤ (Dako); antineurofi lament (Covance); anti-FLAG (Sigma-Aldrich); and anti-GFP (Medical & Biological Laboratories). The rabbit antiserum for Dock7 was generated against a KELFALHP-SPDEEE peptide. The polyclonal anti-Dock7 antibody was affi nity purifi ed using a peptide-conjugated resin. The rabbit antiserum for phosphorylated (pTyr 1118 ) Dock7 was generated against a phosphorylated peptide ETVPQLpYDFTET. The polyclonal anti-(pTyr 1118 )Dock7 antibody was affi nity purifi ed using a phosphorylated peptide-conjugated resin from non adsorbed fractions of a nonphosphorylated peptide ETVPQLYDFTET-conjugated resin. Peroxidase and fl uorescence-labeled secondary antibodies were purchased from GE Healthcare and Invitrogen, respectively. The following inhibitors were purchased: ErbB3-Fc, which possesses the extracellular domain of ErbB3 fused to the Fc region of an IgG (R & D Systems); and C. diffi cile Toxin B, Clostridium botulinum C3 exoenzyme, AG825, SP600125/JNK inhibitor II, and JNK inhibitor I (EMD).
Plasmids
The coding regions of three alternative splicing variants of Dock7 (available from GenBank/EMBL/DDBJ under accession nos. DQ118679 , DQ118680 , and DQ309763 ) were isolated by the method of 5 Ј and 3 Ј rapid amplifi cation of cDNA from human brain (Marathon-Ready cDNA; Clontech Laboratories, Inc.), according to the manufacturer ' s protocol. The major variant DQ118679 was ligated into the mammalian FLAGand GFP-tagged expression vectors pCMV-FLAG and pEGFP-C1. The cDNA fragments encoding DHR-1 (aa 1 -691), middle region 1 (aa 692 -1110), middle region 2 (aa 1111 -1431), and DHR-2 (aa 1432 -1992) of Dock7 were also inserted into pCMV-FLAG. The constructs of the full-length Dock7 harboring the Tyr-1118 -to -Phe, Tyr-1138 -to -Phe, Tyr-1225 -toPhe, Tyr-1233 -to -Phe, Tyr-1375 -to -Phe, or Tyr-1429 -to -Phe mutation and the Y1118F, Y1138F, Y1225F, Y1233F, Y1375F, and Y1429F mutants of the middle region 2 were produced by the overlapping PCR method and ligated into pCMV-FLAG. The wild-type and Y1118, Y1138F, Y1225F, Y1233F, Y1375F, and Y1429F mutants of the full-length Dock7 were also inserted into pEGFP-C1. The wild-type and Y1118, Y1138F, Y1225F, Y1233F, Y1375F, and Y1429F constructs resistant to Dock7-1 siRNA were made by replacing 5 Ј -AAGACGTTCAATGTCAATAGA-3 Ј with 5 Ј -A CGTA G A TCAATG AGT AT T GA-3 Ј at nucleotides 207 -227 without amino acid mutations (underlined nucleotides indicate replacements). The partial nucleotide sequences of mouse and rat Dock7 (Available from GenBank/EMBL/DDBJ under accession nos. DQ109674 and DQ124295 ) were isolated from cDNAs of mouse brain and rat Schwann cells, respectively. The regions encoding ErbB2 and ErbB3 (Available from GenBank/ EMBL/DDBJ under accession no. AY686636 ) were isolated by 5 Ј and 3 Ј rapid amplifi cation of cDNA from mouse brain Marathon-Ready cDNA and subcloned into pCMV. The coding region of ELMO1 was amplifi ed from human brain cDNA and inserted into pCMV-HA. The mammalian expression plasmids pCMV -FLAG -constitutively active Dbs-DHPH and pCMV-MBP-CrkII and the Escherichia coli GST-tag expression plasmids pET42a -Rac1-GTP and Cdc42-GTP binding domain (Cdc42/Rac interactive binding domain [CRIB] ) of Pak1, pET42a wild-type Rho GTPases (Rac1, Cdc42, and RhoA), and pET42a -guanine nucleotide -free Rho GTPases (Rac1G15A, Cdc42G15A, and RhoAG17A) were constructed as previously described ( Yamauchi et al., 2005a , b ) . The mammalian expression plasmids encoding Dock180 were provided by M. Matsuda (Osaka University, Osaka, Japan) and K.S. Ravichandran (University of Virginia, Charlottesville, VA). All sequences were confi rmed by automatic sequencers (Applied Biosystems).
Cell culture
Primary Schwann cells were prepared from sciatic nerves of Sprague-Dawley rats at postnatal day 1 ( Yamauchi et al., 2004 ) . Schwann cells were cultured on poly-lysine -coated dishes in DME containing 10% heat-inactivated FBS and 50 μ g/ml gentamicin at 37 ° C and plated for experiments on collagen (type I)-coated dishes, unless otherwise indicated. Before the experiments were performed, Schwann cells were cultured in Sato medium containing 1 mg/ml BSA for 24 h. DRG neurons were dissociated from rat embryos at gestational day 15, purifi ed, and cultured in DME-GlutaMax of Rac1 and Cdc42 in Cos-7 cells cotransfected with ErbB2 and ErbB3. 
Plasmid transfection
For primary Schwann cells, pEGFP, pEGFP-Dock7-1 siRNA-resistant wildtype, Y1118F, Y1138F, Y1225F, Y1233F, Y1375F, or Y1429F Dock7 was cotransfected with control, Dock7-1, Rac1, or Cdc42-2 siRNA by using the Lipofectamine 2000 reagent or Nucleofector II (Amaxa Biosystems) with the Basic Neuron Nucleofector Transfection kit (Amaxa Biosystems), according to the manufacturer ' s protocol. Transfection effi ciency was 15 -20% using GFP-expressing plasmid as the control. The medium was replaced at 24 h after transfection. To perform the Boyden chamber migration assay, Schwann cells were cultured in Sato medium containing 1 mg/ml BSA for another 24 h. To assay the migration of reaggregated Schwann cells, cells were allowed to form reaggregates in DME containing 10% FBS for another 24 h. For 293T and Cos-7 cells, pCMV-FLAG-Dock7, pCMV-FLAG-Dock7Y1118F, pCMV-FLAG-Dock7Y1138F, pCMV-FLAGDock7Y1225F, pCMV-FLAG-Dock7Y1233F, pCMV-FLAG-Dock7Y1375F, pCMV-FLAG-Dock7Y1429F, pCMV -FLAG-Dock7 -DHR-1, pCMV -FLAGDock7 -middle region 1, pCMV -FLAG-Dock7 -middle region 2 or the Tyr-toPhe mutant, or pCMV -FLAG -Dock7 -DHR-2 was transfected with or without pCMV-ErbB2 and pCMV-ErbB3 using the CalPhos transfection reagent. Transfection effi ciency typically exceeded 95% using GFP-expressing plasmid as the control.
Affi nity precipitation of GEFs
Dock7 proteins or Dbs-DHPH in the cell lysates was affi nity precipitated with 20 μ g GST-Rac1G15A, GST-Cdc42G15A, or GST-RhoAG17A, which are guanine nucleotide -free Rho GTPases. A Gly-to-Ala mutation of residue 15 in Rac1 and Cdc42 or residue 17 in RhoA decreases their nucleotide binding ( Arthur et al., 2002 ) . Active GEFs preferentially interact with guanine nucleotide -free forms of the small GTPases ( Arthur et al., 2002 ; Schmidt and Hall, 2002 ; Rossman et al., 2005 ) . The affi nity precipitation was also performed using 20 μ g GST wild-type Rho GTPase (Rac1, Cdc42, or RhoA). Affi nity-precipitated GEFs were detected by immunoblotting ( Yamauchi et al., 2005a , b ) .
Detection of active Rho GTPases
To detect active GTP-bound Rac1 and Cdc42 in the cell lysates, we performed affi nity precipitation by using 20 μ g GST-Pak1-CRIB, which binds to their GTP-bound forms. To compare the total amount of GTPase, immunoblotting was also performed with an anti-Rac1 or Cdc42 antibody. Two to fi ve separate experiments were performed. The band intensity in the immunoblot was quantifi ed, and the levels of Rac1-GTP and Cdc42-GTP were normalized to the amount of each total GTPase ( Yamauchi et al., 2005a , b ) .
JNK assay
The cell lysates were immunoblotted with an anti-(pThr 183 /pTyr 185 )JNK antibody that recognizes the active form. To compare the total amount of JNK, immunoblotting was also performed with an anti-JNK antibody. Three to fi ve separate experiments were performed. The band intensity in the immunoblot was quantifi ed, and the levels of the phosphorylated forms were normalized to the amount of total kinase.
Statistical analysis
Values shown represent the mean ± SD from separate experiments. Analysis of variance (ANOVA) was followed by Fisher ' s protected least significant difference post hoc comparisons (*, P < 0.01; **, P < 0.015; ***, P < 0.02). Fig. S1 demonstrates that Schwann cell migration requires the activation of the Rho family of small GTPases but is not dependent on Tiam1 or Dbs of the Dbl family GEFs. Fig. S2 characterizes the anti-Dock7 and anti-(pTyr 1118 )Dock7 antibodies. Fig. S3 shows the purifi cation of the DHR-2, wild-type, and Y1118F mutant proteins of Dock7. Fig. S4 illustrates that the middle region 2 of Dock7 inhibits NRG1-induced migration and activation
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